Tyrphostin AG1296, a platelet-derived growth factor receptor inhibitor, induces apoptosis, and reduces viability and migration of PLX4032-resistant melanoma cells

Melanoma is the deadliest form of skin cancer, and BRAFV600E is a driver mutation that promotes melanoma growth and survival. PLX4032 is the first effective compound in clinical use for the treatment of patients with mutant BRAFV600. However, resistance to PLX4032 develops quickly within months. Act...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanling, Li, Yuping, Liu, Qiang, Wang, Aixue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437616/
https://www.ncbi.nlm.nih.gov/pubmed/25999739
http://dx.doi.org/10.2147/OTT.S70691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437616/
https://www.ncbi.nlm.nih.gov/pubmed/25999739
http://dx.doi.org/10.2147/OTT.S70691

Ejemplares similares